Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Raw Materials (2018 - 2025)

Immucell (ICCC) has disclosed Raw Materials for 8 consecutive years, with $1.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Raw Materials rose 42.54% year-over-year to $1.9 million, compared with a TTM value of $1.9 million through Sep 2025, up 42.54%, and an annual FY2024 reading of $1.4 million, down 14.92% over the prior year.
  • Raw Materials was $1.9 million for Q3 2025 at Immucell, up from $1.5 million in the prior quarter.
  • Across five years, Raw Materials topped out at $2.4 million in Q4 2022 and bottomed at $660547.0 in Q1 2021.
  • Average Raw Materials over 5 years is $1.6 million, with a median of $1.5 million recorded in 2025.
  • The sharpest move saw Raw Materials crashed 44.29% in 2024, then soared 42.54% in 2025.
  • Year by year, Raw Materials stood at $660547.0 in 2021, then surged by 266.36% to $2.4 million in 2022, then tumbled by 34.13% to $1.6 million in 2023, then decreased by 14.92% to $1.4 million in 2024, then surged by 38.08% to $1.9 million in 2025.
  • Business Quant data shows Raw Materials for ICCC at $1.9 million in Q3 2025, $1.5 million in Q2 2025, and $1.6 million in Q1 2025.